< Terug naar vorige pagina

Publicatie

A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) : results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)

Boekbijdrage - Boekabstract Conferentiebijdrage

Boek: ANNALS OF ONCOLOGY

Volume: 30

Pagina's: v449 - v450

Jaar van publicatie:2019

Handle: http://hdl.handle.net/1854/LU-8653715
WoS Id: 000491295503157
ArticleNumber: abstract 1109O

Zie ook: A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)